HORMAD1 and triple-negative breast carcinoma: Notably, the role of HORMAD1 and thus meiomitosis is not restricted to SCCs, since other cancers with high mutational burdens, including triple negative breast cancer (TNBC) and lung adenocarcinoma, also express high levels of HORMAD1 [57].